CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
Prazosin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01916941
NCT01916941N/ACompleted

Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin

University of New Mexico·interventional·Posted Aug 6, 2013·Updated Oct 17, 2017

In Brief

A clinical study evaluating Prazosin and Placebo for Alcohol Use Disorder. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The study uses neurobiological measures through brain imaging, neuropsychological measures, and selfreport measures to try to understand how an effective treatment for alcoholism works. On the whole, less than 50% of people with alcoholism get better with treatment. This study will help researchers develop better treatments for alcoholism because if the investigators know why the treatments the investigators use are working, and in whom the treatments work best, then the investigators may be able to make treatment more effective by targeting treatments to individuals who would be most likely to benefit and by guiding development of more effective treatments in the future.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedAug 6, 2013
Enrollment StartSep 1, 2013
Primary CompletionAug 1, 2016
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.9 years ago

Interventions

Prazosindrug

Placebodrug